PA8518601A1 - Combinaciones de carboxialquileter-inhibidor de acat - Google Patents
Combinaciones de carboxialquileter-inhibidor de acatInfo
- Publication number
- PA8518601A1 PA8518601A1 PA20018518601A PA8518601A PA8518601A1 PA 8518601 A1 PA8518601 A1 PA 8518601A1 PA 20018518601 A PA20018518601 A PA 20018518601A PA 8518601 A PA8518601 A PA 8518601A PA 8518601 A1 PA8518601 A1 PA 8518601A1
- Authority
- PA
- Panama
- Prior art keywords
- acat
- carboxialquileter
- inhibitor combinations
- rented
- formula
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/075—Ethers or acetals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/255—Esters, e.g. nitroglycerine, selenocyanates of sulfoxy acids or sulfur analogues thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/08—Vasodilators for multiple indications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
Landscapes
- Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Epidemiology (AREA)
- Diabetes (AREA)
- Urology & Nephrology (AREA)
- Hematology (AREA)
- Vascular Medicine (AREA)
- Obesity (AREA)
- Pulmonology (AREA)
- Hospice & Palliative Care (AREA)
- Emergency Medicine (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
LA INVENCION ES UNA COMPOSICION FARMACEUTICA QUE COMPRENDE UN CARBOXIALQUILETER QUE REDUCE TRIGLICERIDOS Y LDL Y ELEVA EL HDL Y UN INHIBIDOR DE ACAT QUE MEJORA LA DISLIPIDEMIA EN MAMIFEROS, DICHA COMPOSICION ES UTIL PARA TRATAR LA DISLIPIDEMIA Y SINDROMES ISQUEMICOS Y PARA PREVENIR O RETARDAR EL COMIENZO DE ATAQUES CARDIACOS. LOS CARBOXIALQUIETERES TIENEN LA FORMULA EN DONDE Y1 E Y2 INCLUYE COOH, R1, R2, R3 Y R4 PUEDEN SER ALQUILO, Y n Y m SON NUMEROS ENTEROS DE 2 A 9; Y LOS INHIBIDORES DE ACAT TIENEN LA FORMULA EN DONDE R ES HIDROGENO, X ES O, R1 Y R2 SON FENILO SUSTITUIDO, E Y ES ALQUILENO.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US21005600P | 2000-06-07 | 2000-06-07 |
Publications (1)
Publication Number | Publication Date |
---|---|
PA8518601A1 true PA8518601A1 (es) | 2002-07-30 |
Family
ID=22781424
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PA20018518601A PA8518601A1 (es) | 2000-06-07 | 2001-06-05 | Combinaciones de carboxialquileter-inhibidor de acat |
Country Status (14)
Country | Link |
---|---|
EP (1) | EP1292363A2 (es) |
JP (1) | JP2003535125A (es) |
AR (1) | AR034255A1 (es) |
AU (1) | AU2001263003A1 (es) |
BR (1) | BR0111428A (es) |
CA (1) | CA2413906A1 (es) |
GT (1) | GT200100106A (es) |
MX (1) | MXPA02010762A (es) |
PA (1) | PA8518601A1 (es) |
PE (1) | PE20020265A1 (es) |
SV (1) | SV2002000466A (es) |
TN (1) | TNSN01085A1 (es) |
UY (1) | UY26752A1 (es) |
WO (1) | WO2001093845A2 (es) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7387236B2 (en) | 2001-10-09 | 2008-06-17 | Delaware Capital Formation, Inc. | Dispensing of currency |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ATE320803T1 (de) * | 1998-01-28 | 2006-04-15 | Warner Lambert Co | Verfahren zur behandlung von alzheimerschen krankheit |
-
2001
- 2001-05-08 WO PCT/US2001/014804 patent/WO2001093845A2/en active Application Filing
- 2001-05-08 CA CA002413906A patent/CA2413906A1/en not_active Abandoned
- 2001-05-08 BR BR0111428-0A patent/BR0111428A/pt not_active IP Right Cessation
- 2001-05-08 EP EP01937250A patent/EP1292363A2/en not_active Withdrawn
- 2001-05-08 JP JP2002501418A patent/JP2003535125A/ja active Pending
- 2001-05-08 AU AU2001263003A patent/AU2001263003A1/en not_active Abandoned
- 2001-05-08 MX MXPA02010762A patent/MXPA02010762A/es not_active Application Discontinuation
- 2001-05-24 SV SV2001000466A patent/SV2002000466A/es not_active Application Discontinuation
- 2001-06-05 TN TNTNSN01085A patent/TNSN01085A1/en unknown
- 2001-06-05 UY UY26752A patent/UY26752A1/es not_active Application Discontinuation
- 2001-06-05 PA PA20018518601A patent/PA8518601A1/es unknown
- 2001-06-05 PE PE2001000517A patent/PE20020265A1/es not_active Application Discontinuation
- 2001-06-05 GT GT200100106A patent/GT200100106A/es unknown
- 2001-06-06 AR ARP010102688A patent/AR034255A1/es unknown
Also Published As
Publication number | Publication date |
---|---|
EP1292363A2 (en) | 2003-03-19 |
JP2003535125A (ja) | 2003-11-25 |
SV2002000466A (es) | 2002-04-03 |
MXPA02010762A (es) | 2003-03-10 |
TNSN01085A1 (en) | 2005-11-10 |
WO2001093845A2 (en) | 2001-12-13 |
CA2413906A1 (en) | 2001-12-13 |
BR0111428A (pt) | 2003-06-10 |
AR034255A1 (es) | 2004-02-18 |
GT200100106A (es) | 2002-05-20 |
WO2001093845A3 (en) | 2002-10-10 |
UY26752A1 (es) | 2001-07-31 |
PE20020265A1 (es) | 2002-04-19 |
AU2001263003A1 (en) | 2001-12-17 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ECSP024382A (es) | Inhibidores de proteasa de serina | |
AR027788A1 (es) | Proceso de desinfectar una superficie dura con una composicion que comprende aceite de canela y/o un activo de este | |
CO5600999A2 (es) | Composiciones farmaceuticas que comprenden inhibidores de valsartan y endopeptidasa neutra | |
DE69827821D1 (de) | Synergistisch,analgetische zusammensetzung mit opiod-analgetika und zyklooxygenase-2 inhibitoren | |
CR7849A (es) | Agente para la prevencion o tratamiento de neuropatias | |
DK1509232T3 (da) | Kombination af en NMDA-antagonist og acetylcholin-esterase inhibitorer til behandling af Alzheimers sygdom | |
PA8513601A1 (es) | Composiciones farmaceuticas de inhibidores de la glucogenofosforilasa | |
EA200201175A1 (ru) | Применение ингибиторов il-18 для лечения и/или предотвращения атеросклероза | |
BR0308243A (pt) | Composto, formulação farmacêutica, e, métodos de tratar diabetes, doença de alzheimer, e de inibir gsk-3 em um mamìfero | |
CR7332A (es) | INHIBIDORES DEL FACTOR Xa Y DE OTRAS PROTEASAS DE SERINA IMPLICADAS EN LA CASCADA DE LA COAGULACION | |
BRPI0407993B8 (pt) | compostos inibidores de p38 e composições farmacêuticas compreendendo os mesmos | |
PE20020521A1 (es) | Compuestos heterociclicos sustituidos para tratar la resistencia a multiples drogas | |
GT200100152A (es) | Nueva composicion farmaceutica para el tratamiento de la obesidad. | |
GT200100132A (es) | Derivados de pirazol | |
BR0207873A (pt) | Compostos de amÈnio quaternário contendo misturas preservativas | |
PA8529501A1 (es) | Nuevos tiadiazoles y oxadiazoles y su uso como inhibidores de fosfodiesterasa -7." | |
ATE409485T1 (de) | Pharmazeutische zusammensetzungen inhibitoren von fab i und weitere antibiotika enthaltend | |
CY1111566T1 (el) | Συνθεση που περιεχει ελαιο κιτρονελλας ιαβας και η χρησιμοποιηση της για την απωθηση εντομων | |
ME00674B (me) | Disperzioni preparati sa sadržajem inhibitora lipaza | |
ES2421948T3 (es) | Compuestos y composiciones para suministrar agentes activos | |
PA8586801A1 (es) | Inhibidores de hiv-integrasa, composiciones farmaceuticas y metodos para su uso | |
PA8518601A1 (es) | Combinaciones de carboxialquileter-inhibidor de acat | |
BR0108980A (pt) | Aplicação e formulação farmacêuticas compreendendo inibidor de reabsorção de norepinefrina | |
DE50205129D1 (de) | 8-tetradecenal als duft- oder aromastoff | |
AR030487A1 (es) | Una composicion herbicida sinergica de un compuesto de dehidrobenzotiofeno y un inhibidor del fotosistema ii y el metodo para el control sinergico de plantas no deseables con dicha composicion |